Xalvobin
Brand Name: Xalvobin
Generic Name: Capecitabine
Active
Registration Number
DR-XY43140
Dosage Form
Film-Coated Tablet
Issuance Date
January 31, 2024
Expiry Date
February 4, 2029
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength500 mg
PackagingAlu/Clear PVC-PE-PVDC Blister Pack x 10's (Box of 120's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic
A
Application
Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
CapecitabineActive
Monograph: Capecitabine